{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:13Z","timestamp":1792115053813,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.contraception.2026.111553","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:39:20Z","timestamp":1783147160000},"page":"111553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative effectiveness of 200\u202fmcg versus 400\u202fmcg misoprostol dosing for medication abortion from 24 to 27 weeks' gestation"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-5174","authenticated-orcid":false,"given":"Theresa","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita A.","family":"Kakkad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Oot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2026.111553_bib1","doi-asserted-by":"crossref","unstructured":"Kortsmit K., Nguyen A.T., Mandel M.G., Hollier L.M., Ramer S., Rodenhizer J., et al. Abortion surveillance - united states, 2021 [Internet]. Centers for Disease Control and Prevention; 2023 [cited 2025 Dec 12]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/ss\/ss7209a1.htm?s_cid=ss7209a1_w.","DOI":"10.15585\/mmwr.ss7209a1"},{"key":"10.1016\/j.contraception.2026.111553_bib2","unstructured":"Abortion in the United States [Internet]. 2025 [cited 2025 Dec 12]. Available from: \u3008https:\/\/www.guttmacher.org\/fact-sheet\/induced-abortion-united-states\u3009."},{"key":"10.1016\/j.contraception.2026.111553_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110202","article-title":"Change in clinic volume and gestational age at time of abortion in Southern Illinois before and after Dobbs V Jackson Women\u2019s Health Organization","volume":"127","author":"Trevino","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2026.111553_bib4","unstructured":"Gomez I., Salganicoff A., Sobell L. Abortions later in pregnancy in a Post-Dobbs era [Internet]. 2025 [cited 2025 Dec 12]. Available from: \u3008https:\/\/www.kff.org\/womens-health-policy\/abortions-later-in-pregnancy-in-a-post-dobbs-era\/\u3009."},{"key":"10.1016\/j.contraception.2026.111553_bib5","unstructured":"Russo J., Bartz D.A. Abortion after 24 0\/7 weeks of gestation. In: Chakrabarti A, editor. UpToDate [Internet]. [cited 2025 Dec 12]. Available from: \u3008https:\/\/www.uptodate.com\/contents\/abortion-after-24-0-7-weeks-of-gestation#H4264002003\u3009."},{"issue":"3","key":"10.1016\/j.contraception.2026.111553_bib6","doi-asserted-by":"crossref","DOI":"10.12788\/obgm.0267","article-title":"Advances in the treatment of fetal demise in the second and Third trimester","volume":"35","author":"Barbieri","year":"2023","journal-title":"OBG Manag"},{"key":"10.1016\/j.contraception.2026.111553_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110143","article-title":"Society of Family Planning Clinical Recommendation: medication abortion between 14 0\/7 and 27 6\/7 weeks of gestation","volume":"129","author":"Zwerling","year":"2024","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2026.111553_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/AOG.0000000000004344","article-title":"Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation","volume":"137","author":"Allanson","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2026.111553_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2020.02.007","article-title":"Mifepristone pretreatment followed by misoprostol 200 MCG buccal for the medical management of intrauterine fetal death at 14\u201328 weeks: A randomized, placebo-controlled, double blind trial","volume":"102","author":"Bracken","year":"2020","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2026.111553_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s13224-011-0118-4","article-title":"Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy","volume":"61","author":"Nagaria","year":"2011","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.contraception.2026.111553_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110080","article-title":"Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol","volume":"125","author":"Dickinson","year":"2023","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2026.111553_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (redcap)\u2014a metadata-driven methodology and workflow process for providing Translational Research Informatics Support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Informat"},{"key":"10.1016\/j.contraception.2026.111553_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The redcap consortium: building an international community of Software Platform Partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Informat"},{"key":"10.1016\/j.contraception.2026.111553_bib14","series-title":"R: A language and environment for statistical computing (Version 4.5) [Internet]","author":"R Core Team","year":"2026"},{"issue":"7","key":"10.1016\/j.contraception.2026.111553_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","article-title":"High fever following postpartum administration of sublingual misoprostol","volume":"117","author":"Durocher","year":"2010","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"2","key":"10.1016\/j.contraception.2026.111553_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.contraception.2011.01.005","article-title":"Infection and extramural delivery with use of Digoxin as a feticidal agent","volume":"85","author":"Steward","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2026.111553_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.contraception.2011.05.016","article-title":"Safety of Digoxin for fetal demise before second-trimester abortion by dilation and evacuation","volume":"85","author":"Dean","year":"2012","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782426001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:48:22Z","timestamp":1792111702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782426001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":17,"alternative-id":["S0010782426001903"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111553","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of 200\u202fmcg versus 400\u202fmcg misoprostol dosing for medication abortion from 24 to 27 weeks' gestation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2026.111553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111553"}}